Glioma Cells Transduced with Selection Transgenes May Not Form Gliomas in vivo and Can Also Inhibit Glioma Formation by Admixed Wild Glioma Cell Lines

Acta Neurochirurgica, Supplement

Volumn 1997, Issue 68, 1997, Pages 139-143

  Whittle, I R ^a   Kimber, W L ^a   Li, M ^a   Bell, H S ^a   Ironside, J W ^a  

^a WESTERN GENERAL HOSPITAL   (United Kingdom)

Author keywords

Bystander effect; Gene therapy; Glioma

Indexed keywords

GANCICLOVIR; HYGROMYCIN B KINASE; HYGROMYCIN-B KINASE; PHOSPHOTRANSFERASE; THYMIDINE KINASE;

ANIMAL; ARTICLE; BRAIN; BRAIN TUMOR; CANCER TRANSPLANTATION; CELL CULTURE; CELL SURVIVAL; CELL TRANSFORMATION; CYTOMEGALOVIRUS; GENE THERAPY; GENE TRANSFER; GENETIC TRANSDUCTION; GENETICS; GLIOMA; HUMAN; PATHOLOGY; RAT; TRANSGENE; WISTAR RAT;

ANIMALS; BRAIN; BRAIN NEOPLASMS; CELL SURVIVAL; CELL TRANSFORMATION, NEOPLASTIC; CYTOMEGALOVIRUS; GANCICLOVIR; GENE THERAPY; GENE TRANSFER TECHNIQUES; GLIOMA; HUMANS; NEOPLASM TRANSPLANTATION; PHOSPHOTRANSFERASES (ALCOHOL GROUP ACCEPTOR); RATS; RATS, WISTAR; THYMIDINE KINASE; TRANSDUCTION, GENETIC; TRANSGENES; TUMOR CELLS, CULTURED;

EID: 0030633152     PISSN: 00651419     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-3-7091-6513-3_26     Document Type: Article

References (17)

1. Barba D, Hardin J, et al (1994) Development of anti-tumor immunity following thymidine kinase-mediated killing of experimental brain tumors. Proc Natl Acad Sci USA 91: 4348-4352
2. Beaumont A, Clarke M, Whittle IR (1996) The effects of malignant glioma on the EEG and seizure thresholds; an experimental study. Acta Neurochir (Wien) 138: 370-381
3. Culver KW, Ram Z, Walbridge S et al (1992) In vivo gene transfer with retroviral vector producer cells for treatment of experimental brain tumors. Science 256: 1550-1552
4. Freeman SM, Abboud C, Whartenby K et al (1993) The "bystander effect": Tumor regression when a fraction of the tumor mass is genetically modified. Cancer Res 53: 5274-5283
5. Kramm CM, Sena-Esteves M et al (1995) Gene therapy for brain tumours. Brain Pathol 5: 346-381
6. Lichtor T, Glick RP et al (1995) Prolonged survival of mice with glioma injected intracerebrally with double cytokine-secreting cells. J Neurosurg 83: 1038-1044
7. Lupton SD, Brunton LL, Kalberg VA et al (1991) Dominant positive and negative selection using a hygromycin phosphotransferase-thymidine kinase fusion gene. Mol Cell Biol 11: 3374-48
8. Malcolm G, Kelly PA, Whittle IR et al (1995) Experimental implantation glioma using the A15A5 cell line. J Neurol Neurosurg Psychiatry 58: 390-191
9. MacArthur D, Malcolm G, Ironside JW, Whittle IR (1995) Can experimental models of implantation glioma be improved? Br J Neurosurg 9: 251-252
10. Moolten FL, Wells JM (1990) Curability of tumors bearing herpes thymidine kinase genes transferred by retroviral vectors. J Natl Cancer Inst 82: 297-300
11. Samejima Y, Meruelo D (1995) "Bystander killing" induces apoptosis and is inhibited by forskolin. Gene Ther 2: 50-58
12. Schwartz MS, Morris J, Sarid J (1991) Overexpression of oncogene products can cause tumor progression without parenchymal infiltration in the rat brain. Cancer Res 50: 3595-3601
13. Takamiya Y, Short MP, Ezzadine ZD et al (1992) Gene therapy of malignant brain tumors: a rat glioma line bearing the herpes simplex virus type a-thymidine kinase gene and wild type retrovirus kills other tumor cells. J Neurosci Res 33: 493-503
14. Tapscott SJ, Miller AD et al (1994) Gene therapy of rat 9L gliosarcoma tumors by transduction with selectable genes does not require drug selection. Proc Natl Acad Sci USA 91: 8185-8189
15. Vrionis FD, Wu JK, Qi P et al (1996) Tumor cells expressing the herpes simplex virus-thymidine kinase gene in the treatment of Walker 256 meningeal neoplasia in rats. J Neurosurg 84: 250-257
16. Wu JK, Cano WG, Sven AG et al (1994) Bystander tumoricidal effect in the treatment of experimental brain tumours. Neurosurgery 35: 1094-1103
17. Whittle IR, Macarthur DC, Malcolm GP et al (1996) Can experimental implantation models of rodent glioma be improved? A study of pure and mixed glioma cell line tumours. Acta Neurochir (Wien) submitted